Home
Our Story
Our People
Partners
Contact
Our Approach
Our Science
Pipeline
Our Culture
Careers
Our News
Posters & Presentations
search
Our News
Newsroom
The latest news and developments in our continuing effort to break barriers, one gene at a time.
June 24, 2022
Mutant allele knockout with novel CRISPR nuclease promotes myelopoiesis in ELANE neutropenia
Cell
More
April 24, 2022
Emendo Biotherapeutics to present at the American Society of Gene & Cell Therapy annual conference
Conference
More
April 17, 2022
Emendo Biotherapeutics to present at upcoming BioMed 2022
Conference
More
December 16, 2021
CRISPR innovation hits the gas
Biocentury
More
January 15, 2020
Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits
Xconomy
More
January 15, 2020
Fifth Emendo-ment: Next-wave gene editing process gets its due, eminent in domain as more board the Omni-bus
Bio World
More
January 15, 2020
Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D
Xconomy
More
January 15, 2020
Takeda hops onto $61M round for CRISPR player synthesizing Cas9 alternatives
Endpoint News
More
1
2
close
Search for: